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Abstract
Background The long-term effects of presurgical psychological interventions on weight loss, eating behaviors, affective symp-
toms, and health-related quality of life remain uncertain. This study aimed to assess the 4-year effects of cognitive behavioral
therapy (CBT) before bariatric surgery on these outcomes.
Methods Single-center randomized controlled parallel-group trial. Patients were assessed after CBT before bariatric surgery (n =
98) and 1 year (n = 80) and 4 years (n = 61) after surgery. The intervention group received a 10-week preoperative individual
CBT focusing on self-monitoring to identify triggers of dysfunctional eating behaviors in order to improve regulation of eating as
well as the breaking of the interrelationship between eating behaviors, negative mood, and dysfunctional cognitions.
Results The 61 patients (70% women) had a mean (SD) age of 42.4 (10.1) years and BMI 43.5 (4.4) kg/m2. Preoperative CBTwas
not associated with 1- and 4-year reduction of dysfunctional eating behaviors, affective symptoms and body weight, or improved
health-related quality of life. Patients with minor or considerable symptoms of depression receiving CBT had lower mean BMI than
controls, both before surgery, − 1.1 kg/m2, and − 1.5 kg/m2, and 4-years after surgery, − 2.9 kg/m2 and − 7.5 kg/m2, respectively.
Conclusion Presurgical CBTwas not associated with better long-term outcomes. However, in patients with minor or considerable
symptoms of depression, CBT was associated with lower body weight before and 4 years after surgery. Additional studies are
required to verify whether patients with symptoms of depression should be offered CBT before and/or after bariatric surgery, and
which clinical aspects the CBT should address.
Trial Registration Clinicaltrials.gov Identifier: NCT01403558.
Keywords Cognitive behavioral therapy .Weight loss . Eating behaviors . Depression . Health-related quality of life
Introduction
Mental health and eating behaviors may improve after bariat-
ric surgery, and these beneficial effects may affect weight loss
and maintenance [1–6]. However, these benefits do not seem
to endure beyond the years immediately after surgery [7, 8],
and bariatric surgery has been associated with increased long-
term risk of new onset of depression, anxiety, and sleep dis-
orders [9]. Furthermore, although the average long-term
weight loss after bariatric surgery is satisfactory, the general
reporting of mean weight values probably underestimates the
extent of weight regain [10]. Importantly, emotional and un-
controlled eating, as well as anxiety or depression, may in-
crease weight regain due to an association between these men-
tal health symptoms and poor weight loss [6, 11].
Preoperative medical weight management may promote post-
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More specifically, few clinical studies have evaluated the short- to
medium-term effects of presurgical behavioral interventions on
postsurgical weight loss [13–15], while the long-term (≥ 2 years)
effects of presurgical psychological interventions on weight loss
and mental health outcomes remain uncertain [16]. We previous-
ly found, however, in a randomized controlled trial (RCT) that a
10-week preoperative cognitive behavioral therapy (CBT) signif-
icantly reduced dysfunctional eating behaviors, affective symp-
toms, and body weight before surgery [17], but that these effects
disappeared at 1-year follow-up [18]. A smaller pilot RCT dem-
onstrated that six sessions of telephone-based CBT before bariat-
ric surgery was associated with improved eating psychopatholo-
gy and depression [19]. In addition, a retrospective chart review
study showed that a brief cognitive behavioral group psychother-
apy was associated with reduced binge eating behaviors among
bariatric surgery candidates [20]. Although it has been hypothe-
sized that postoperative eating adaptation and depression may
affect later weight loss, the evidence is insufficient [21].
The present 4-year follow-up of a previously published
randomized controlled study [17] aimed to assess whether a
10-week presurgical CBT intervention implied favorable
long-term improvements in eating behaviors, weight loss, af-
fective symptoms (anxiety and depression), and health-related
quality of life (HRQoL). In addition, it explored whether
changes in the mental health status (i.e., affective symptoms,
notably depression), as well as mental health-related vulnera-
bility (neuroticism) and protective factors (resilience), modi-
fied the treatment response in terms of body weight (BMI) in
the follow-up period. We hypothesized that a 10-week
presurgical CBT intervention would improve long-term eating
behaviors, weight loss, and affective symptoms.
Materials and Methods
Trial Design, Setting, and Participants
This 4-year follow-up of a single-center parallel-group RCT
(http://clinicaltrials.gov/ct2/show/NCT01403558) was
conducted at a tertiary care center in Norway [17, 18]. Patients
preparing for bariatric surgery were enrolled from September
2011 to June 2012. Measurements were carried out 4 months
and 4 weeks before bariatric surgery (T0 and T1), and at 1 and
4 years (T2 and T3) after surgery. All participants signed an
informed consent and were randomly assigned to CBT or
standard preoperative care in a 1:1 ratio [17].
Interventions
The interventions have been described in detail [17]. Briefly, all
patients were offered voluntary consultations from either a med-
ical doctor, a dietician, a nurse, or a physical therapist tailored to
the patients’ individual needs. In the psychological treatment
arm, each patient received an additional individual 10-week
CBT intervention. This intervention focused on self-monitoring
to identify triggers of dysfunctional eating behaviors in order to
improve regulation of eating as well as the breaking of the inter-
relationship between eating behaviors, negative mood, and dys-
functional cognitions (Table 1). A total of 48 out of 50 patients
randomized to intervention completed all sessions.
Prespecified Outcomes
The primary outcomes were dysfunctional eating behaviors:
emotional eating (EE), uncontrolled eating (UE), and cogni-
tive restraint (CR). The secondary outcomes were weight loss
and affective symptoms (depression and anxiety), and explor-
atory outcomes were HRQoL.
Measurements
The clinical data were collected through a web-based solution
(https://no.surveymonkey.com/ and https://metreno.com/).
Body weight, height, eating behaviors, and symptoms of
anxiety and depressions were measured at all time points
(T0–T3). Personality traits were measured at baseline (T0),
and resilience and HRQoL were measured at T2 and T3.
Dysfunctional Eating Behaviors
The Three-Factor Eating Questionnaire (TFEQ R-21) has been
validated for use in individuals with obesity [22, 23]. It consists
of 21 items comprising the 3 subscales: EE (6 items; Cronbach’s
α = .92), UE (9 items; α= .73), and CR (6 items, α = .84). They
were transformed to a 0–100 scale to become comparable.
Higher scores indicate higher levels of dysfunction.
Anxiety and Depression
The Hospital Anxiety and Depression Scale (HADS) includes 7
items assessing non-vegetative symptoms of depression (HADS-
D subscale) and 7 items assessing non-vegetative symptoms of
anxiety (HADS-A subscale) [24]. Items are scored from 0 to 3
with a total score range 0–21 for each subscale. The reliability
and validity of the HADS are well supported in Norwegian pa-
tient samples, and a cut-off score≥ 8 is used to indicate a tentative
diagnosis of depression or anxiety [25, 26].
Neuroticism
The Norwegian version of the NEO Personality Inventory-
Revised (NEO PI-R) was used [27]. The NEO PI-R is based
on the five-factor model (FFM) of personality [28]. Five trait
domains are measured by 240 items on a 5-point Likert scale,
where higher scores indicate more of the domains. In the pres-
ent study, the domain neuroticism (N) was used.
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Resilience
Mental health promoting resilience resources were assessed at
the 1- and 4-year follow-ups (T2, and T3, respectively), using the
Resilience Scale for Adults (RSA) [29]. It is a reliable and valid
scale for assessing protection against hopelessness and depres-
sion when exposed to life stressors or adversity [30]. Higher
scores imply better protection. A global RSA score was used
in the present study, supported by a principal component analysis
extracting a single eigenvalue > 1 (λ = 3.71, R2 = 61.9%).
Weight-Related HRQoL
The short form of impact of weight on quality of life
(IWQOL-lite) is a 31-item questionnaire which assesses the
impact of weight on quality of life with acceptable validity and
reliability in patients with obesity (test-rest reliability r =
0.74–0.91; α = .85). It contains the five domains, i.e., physical
function, self-esteem, sexual life, public distress, and work
[31, 32]. An overall score was used, as a principal component
analysis extracted a single component with an eigenvalue > 1
(λ = 3.21, R2 = 64%). This measure was used at T2 and T3.
Body Weight and BMI
A digital scale (Soehnle Professional 2755, http://www.
soehnle.de/), a bioelectrical impedance analyzer (Tanita BC-
418), and a wall-mounted stadiometer (Seca 240, http://www.
stadiometer.com/) were used to measure body weight and
height, respectively, and BMI was calculated. All patients
were examined in light clothing and without shoes.
Table 1 Overview of the 10-
week CBT intervention Sessions Session content
Session 1 (face-to-face)
Both groups
• Establishing rapport with the patient in order to facilitate a good therapeutic
working alliance.
• Providing information about the interventions to all patients.
• Conducting the baseline measurements and perform the randomization
and informing the patients about their allocated group.
Session 2 (face-to-face) • Introduction to the underlying principles of the therapy (working
transparently, collaboratively, time-limited, and using a manual).
• Informing the patient about CBT and the treatment plans in the study.
• Psychoeducation focusing on the relationships between eating behaviors,
cognitive and behavioral patterns, affect regulation, and obesity, thus
introducing the patients to the CBT model.
• Introducing and explaining homework sheets for sessions 3 and 4.
Sessions 3 + 4 (telephone) • Reviewing the patient’s homework sheets.
• Recognizing and addressing dysfunctional eating behaviors.
• Working with the patient’s behavioral eating patterns (what triggers
eating), and the associated cognitions and emotions.
• Providing the patients’ means to assess their own perception about
recognizing improvement in dysfunctional cognitions and eating
behaviors.
Session 5 (face-to-face) • Coping with situational Btriggers^ that may lead to dysfunctional
cognitive and eating behavioral patterns.
• Working with the patient’s cognitive and behavioral eating patterns
(Btriggers,^ cognition, emotion, and eating behavior).
• Introducing and explaining homework sheets for sessions 6 and 7
Sessions 6 and 7 (telephone) • Reviewing the patient’s homework sheets.
• Continuing the intervention techniques.
• Reinforcing positive changes in eating behaviors.
Session 8 (face-to-face) • Continuation or refining intervention techniques (as session 5) by
guiding the patient in avoiding situational Btriggers^ and making
a plan for practicing new eating behaviors.
• Introducing and explaining home-work sheets for sessions 9 and 10.
Sessions 9 and 10 (telephone) • Reviewing the patient’s home-work sheets.
• Continuation or refining intervention techniques.
Session 11 (face-to-face) • Relapse prevention.
• Ending of treatment and helping the patient to maintain positive changes.
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Sample Size
The original sample size calculation required a minimum of 80
patients to detect ≥ 15% reduction in dysfunctional (emotional
and uncontrolled) eating scores among at least 30% of the
patients in the intervention, compared with none in the control
group (based on power = 90%, alpha = 5%). Expecting a 20%
withdrawal rate, 102 patients were recruited [17].
Randomization
A block randomization procedure (www.randomizer.org) was
employed (blocks of 4) to ensure balance between the groups.
The allocation ratio was 1:1 [17].
Ethics
The studywas approved by the Regional Committee forMedical
and Health Research Ethics (REK Sør-øst, ID no. 2010/2071),
and it satisfies the Declaration of Helsinki standard [33].
Statistical Methods
The longitudinal treatment response was examined with the
mixed regression module as the restricted maximum likeli-
hood function estimates unbiased model parameters using all
the available data; thus, tolerating attrition of participants bet-
ter than conventional analysis of variance methods. The pre-
test score was used as a covariate to increase the statistical
power for detecting changes across the three posttest measures
[34]. Questionnaire data: The dependency in the fitted resid-
uals were accounted for by specifying a compound symmetry
(constant correlations) or an autoregressive (falling correla-
tions) matrix, depending on whichever model fit best (lowest
Bayesian information criteria, BIC). BMI data: An unstruc-
tured covariance matrix had to be used to account for the large
differences in the fitted residual variances (T2 and T3 consid-
erably larger than T1), as well as the residual correlations (T2
and T3 were strongly correlated, whereas T1–T2 and T1–T3
were not). The robust method (Huber-White estimator) was
used to yield a consistent estimate of this covariance matrix.
Degree of freedom was computed using Satterthwaite approx-
imation. A log link function was used to completely normalize
the fitted residuals. The fixed factors were as follows: group
(0 = control, 1 = CBT) representing the overall treatment ef-
fect, time (three posttest measures) representing change in the
follow-up period, and the group × time interaction
representing a particular treatment response at specific time
points only. Differences between the treatment arms were ex-
amined with planned comparison at each time point (least
square difference tests). Type III F-tests and an alpha level
of P < .05 were used. Standardized group mean differences
were calculated as Hedge’s g ¼ EM1−EM2 J correction, using the adjust-
ed means in the nominator and the observed pooled SD for the
specific time point in the denominator, as recommended by
Feingold [35]. Effect sizes were interpreted as negligible,
small, medium, or large for d’s < .20, .20–.49, .50–.79, or
≥ .80, respectively [36]. The patient background variables
(gender and age), the primary (EE, UE, and CR) and the sec-
ondary (HADS-A and HADS-D) outcome variables, and vul-
nerability (neuroticism) and protective factors (resilience) were
examined in separate regression models as moderators of the
treatment effect (M × group andM × group × time). Their main
and interaction with time effects (M andM × time) were includ-
ed for adjustment purposes. Repeatedly assessed moderators
were treated as time-variant variables (e.g., depression), where-
as those recorded once were treated as time-invariant (e.g., gen-
der). A significant moderation effect indicates that change in the
moderator was associated with the treatment response (M ×
group), and whether it was particularly pronounced at certain
time points (M × group × time). P values less than .05 were
considered statistically significant. All analyses were performed
using SPSS version 24 (SPSS Inc).
Results
Participant Characteristics
As previously reported, 102 treatment-seeking white patients
were allocated to either a 10-week presurgical CBT intervention
or standard presurgical care (T0), and after exclusion of 2 pa-
tients in each treatment group due to trial fatigue, data from 98
patients were available for analysis before surgery (T1) (Fig. 1)
[17]. After exclusion of 4 patients who did not undergo bariatric
surgery and 2 who died, 92 patients were invited to participate
in the present 4-year follow-up study, and 61 (66%) patients
accepted the invitation. At baseline (T0), these 61 patients (70%
women) had amean (SD) age of 42.4 (10.1) years and a BMI of
43.5 (4.4) kg/m2 (Table 2). The patients who completed the 4-
year follow-up did not differ significantly from those who did
not, regarding gender distribution, age, BMI, dysfunctional eat-
ing, or affective symptoms.
Primary Outcomes
The three eating behaviors outcomes showed a comparable
treatment response as all group effects (EE F1,96 = 4.82,
P = .031; UE F1,90 = 11.01, P < .001; CR F1,89 = 12.77, P
< .001) and group × time effects (EE F2,154 = 10.79, P
< .001; UE F2,152 = 13.81, P < .001; CR F2,146 = 6.11,
P = .003) were significant (Table 3). As previously reported,
planned comparison showed a significant treatment response
post-intervention (T1, all P’s < .001) with large statistical
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effect sizes. All these effects disappeared 1 year (T2) [18] and
4 years (T3) after surgery, as none planned comparisons were
significant, and the effect sizes were small or negligible (Table
3). While the control group showed significantly higher emo-
tional eating and uncontrolled eating scores than the CBT
group at T1, the results were reversed at T3 showing that the
control group had numerically lower (non-significant) mean
scores than the CBT group.
Secondary Outcomes
As previously reported, the CBT treatment reduced affective
symptoms significantly and strongly before surgery (T1;
Table 3). At 1-year follow-up (T2), the treatment benefit on
depression disappeared, while the anxiety reduction benefit
remained significant and of moderate statistical effect size
(Table 3). At the 4-year follow-up (T3), all differences disap-
peared. Depression scores were even moderately higher in the
CBTcompared to the control arm despite the scores being low
and within the normal range.
BMI Neither group (P = .89) nor the group × time (P = .20)
interaction was significant, whereas time was significant
(F2,67 = 389.93, P < .001). Despite the non-significant interac-
tion, planned comparisons showed a small but significant ben-
efit of CBTon BMI at T1 as previously reported (Table 3) [17].
Exploratory Outcomes
HRQoL did not differ significantly between groups, but the
group × time effect was significant (F1,59 = 7.38, P = .009).
Planned comparisons of the group means at 1-year follow-
up (CBT = 89.4 and control = 86.9, mean difference = 2.5,
95% CI − 3.2 to 8.2, P = .39) and 4-year follow-up (83.3 and
88.3, mean difference = − 5.0, 95% CI − 11.2 to 1.2, P = .11)
confirmed a zig-zag pattern.
Moderator Analyses of BMI: Did Certain Subgroups
Respond to the CBT Treatment?
Gender, age, eating patterns, HADS-A, and neuroticism did
not significantly moderate the effect of CBT on BMI. Only
resilience (RSA) and HADS-D emerged as significant moder-
ators, of which RSA dropped out as non-significant if ana-
lyzed together with HADS-D. The final interaction model




EnrollmentFig. 1 Participant flow through
enrollment, allocation, and
follow-up
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HADS-D × time (F2,43 = 12.30, P < .001), HADS-D × group
(F1,97 = 7.87, P = .006), and HADS-D × group × time (F2,43 =
3.37, P = .044). Since HADS-D was continuously scored,
planned comparison tests were based on estimated means for
patients with absolutely no symptoms of depression (HADS-
D = 0, standardized Z-score = − 0.92), minor symptoms of de-
pression (HADS-D = 4, Z = 0.41), and considerable symp-
toms of depression (HADS-D = 8, Z = 2.06). Figure 2 shows
that CBTwas associated with a significantly lower BMI at T1
(before surgery) and T3 (4 years after surgery) among patients
with HADS-D = 4 or HADS-D = 8; mean differences at T1
and T3 for those with HADS-D = 4, − 1.05 kg/m2 (95% CI,
− 1.58 to − 0.52), and − 2.85 kg/m2 (95% CI, − 5.08 to −
0.62), and for HADS-D = 8, − 1.46 kg/m2 (95% CI, − 2.23
to − 0.69), and − 7.52 kg/m2 (95% CI, − 11.97 to − 3.07).
The CBT intervention had no significant effect at the 1-year
follow-up irrespective of depression scores. The group com-
parisons at all posttests were non-significant for patients with
no symptoms of depression. In addition, patients with no
symptoms of depression in the follow-up period were weight
stable between the 1- and 4-year follow-ups after bariatric
surgery, independent of presurgical treatment (Fig. 2).
Discussion
This 4-year follow-up of an RCT assessed the effects of a 10-
week CBT intervention aiming to reduce dysfunctional eating
behaviors before bariatric surgery. Generally, the study did not
demonstrate any clinically noteworthy long-term effects of the
intervention on dysfunctional eating behaviors, affective symp-
toms, or body weight. One possible explanation may be the
particularly strong effects of bariatric surgery itself on all out-
comes [18, 37]. Our findings concurwith the fact that the average
long-termweight-reducing effect of even high-quality non-surgi-
cal obesity treatment including elements of behavioral therapy is
nearly negligible as compared with the corresponding effect of
gastric bypass (5% at 8 years vs 27% at 12 years) [38, 39].
A small immediate treatment effect of CBT on BMI disap-
peared at the 1- and 4-year follow-ups, respectively. However,
explorative analyses showed a significant moderator role of
depressive symptoms during the follow-up period, as CBT-
treated patients with minor or considerable symptoms of depres-
sion had a significantly larger weight loss immediately after
CBT before surgery (− 1.05 kg/m2 and − 1.46 kg/m2), and
4 years after bariatric surgery (− 2.85 kg/m2 and − 7.52 kg/
m2), than the control group. The discrepancy between the sig-
nificant immediate and 4-year effects of CBT and the lack of 1-
year effect might have several explanations. First, although the
CBT before surgery did not focus on weight loss, it is plausible
that the considerable CBT-related improvement in eating behav-
iors and reduction of affective symptomsmight have contributed
to the small weight loss before surgery [11, 16, 17, 21]. Second,
the large effect of bariatric surgery at 1 year on both groups
might have overshadowed a smaller effect of CBT. Third, the
declining effect of bariatric surgery and weight regain between 1
and 4 years after surgery were seen particularly in patients in the
control group with symptoms of depression, while those with
symptoms of depression who had received CBTseemed to have
been better protected against weight regain.
Although the findings need confirmation, patients with de-
pression are at greater risk for long-term weight regain after
bariatric surgery, and presurgical CBT intervention may miti-
gate this problem. Further, it is plausible that a CBT interven-
tion for patients with depression at 1–2 years following sur-
gery might be even more efficient, as the most profound bio-
logical impacts of bariatric surgery are decreasing and emo-
tional elements may play a bigger role in overall well-being
and weight loss (Fig. 2).
The notion of a preventive effect of CBT in patients with
symptoms of depression may be at odds with the fact that at
the 4-year follow-up, the CBT group scored higher on the
HADS-D measure than the control group. This may represent
a floor effect generated by a markedly higher variance in the
CBT (SD = 3.5) compared to the control group (SD = 1.9)
given the generally low depression scores in both groups.
Thus, scores in the CBT arm could only vary upwards.
Furthermore, at the 4-year follow-up, the correlation between
the residualized change score for BMI (regressing the last
BMI score on BMI baseline) and HADS scores was signifi-
cantly positive in the control group (r = .53, P = .002), but not
in the CBT group (r = .18, P = .36).
Table 2 Baseline demographics
of the 61 patients examined at 4-
year follow-up
Total (n = 61) Intervention (n = 28) Controls (n = 33) P value
Female (yes) 43 (70%) 16 (57%) 27 (82%) .05
Age (years) 42.4 (10.1) 44.4 (10.0) 40.6 (10.2) .16
BMI 43.5 (4.4) 43.6 (4.5) 43.5 (4.4) .97
Procedure
Gastric bypass 49 (80%) 23 (82%) 26 (79%) > .99
Sleeve 12 (20%) 5 (18%) 7 (21%)
Data are presented as observed mean (SD) or number (%), independent samples test or Fisher’s exact test as
appropriate
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One previous RCT reported no significant effects of adju-
vant pre- and postoperative CBTon weight loss, eating habits,
or physical exercise 2 years after gastric bypass [14], while
another RCT demonstrated that a comprehensive lifestyle in-
tervention program with a cognitive behavioral component
before surgery did not improve weight loss 2 years after sur-
gery [13]. However, different study designs make it difficult to
compare the previous studies with the present. First, while the
previous studies used CBT as a part of a lifestyle intervention
program aiming to improve weight loss, the CBT intervention
in the present study focused on strategies to improve dysfunc-
tional eating behaviors. Second, the previous studies also in-
cluded postsurgical treatment [13, 14].
To the best of our knowledge, this is the first long-term (>
2 years) RCT aiming to address the adjuvant somatic and
psychological effects of CBT.
This study has limitations. First, as common in obesity
research, the attrition rate was relatively high at 4 years, which
reduced the statistical power to detect hypothesized differ-
ences in the longitudinal outcomes. The sample size was
based on < 20% attrition rate at T1, it was < 4%, but attrition
increased to 34% during the 4-year follow-up period. To re-
duce bias and loss of power, linear mixed regression models
were fitted [40]. Second, all patients were recruited from a
Norwegian public tertiary care center, with no personal costs
for patients, which might not apply for privately financed
health care systems. Third, resilience and health-related qual-
ity of life were measured only at 1 and 4 years after surgery.
Fourth, all patient were white, reducing the generalizability of
results to non-white populations.
Preoperative CBTwas not associated with improved eating
behaviors, affective symptoms, or weight loss 4 years after
bariatric surgery. However, in patients with minor or
considerable symptoms of depression, CBT was associated
with lower body weight before and 4 years after surgery. To
enhance possible direct immediate and longer term additional
effects of CBT on weight loss, patients with symptoms of
presurgical depression may be offered CBT targeting such
symptoms as well as aspects of dysfunctional eating patterns.
Additional studies are required to assess whether patients
should be offered CBT before and/or after bariatric surgery, as
well as which clinical aspects (e.g., eating behaviors, affective
symptoms, or weight loss) the CBT should in particular
address.
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